Zhouguang Hui

3.3k total citations
145 papers, 1.7k citations indexed

About

Zhouguang Hui is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Zhouguang Hui has authored 145 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Pulmonary and Respiratory Medicine, 51 papers in Oncology and 45 papers in Surgery. Recurrent topics in Zhouguang Hui's work include Lung Cancer Diagnosis and Treatment (64 papers), Lung Cancer Treatments and Mutations (48 papers) and Esophageal Cancer Research and Treatment (34 papers). Zhouguang Hui is often cited by papers focused on Lung Cancer Diagnosis and Treatment (64 papers), Lung Cancer Treatments and Mutations (48 papers) and Esophageal Cancer Research and Treatment (34 papers). Zhouguang Hui collaborates with scholars based in China, United States and United Kingdom. Zhouguang Hui's co-authors include Zongmei Zhou, Lühua Wang, Jun Liang, Zefen Xiao, Yu Men, Qinfu Feng, Dongfu Chen, Jima Lv, Nan Bi and Yirui Zhai and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Zhouguang Hui

133 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhouguang Hui China 22 1.1k 575 461 378 256 145 1.7k
Zongmei Zhou China 24 1.1k 1.0× 558 1.0× 484 1.0× 470 1.2× 147 0.6× 142 1.7k
Zefen Xiao China 25 1.2k 1.1× 603 1.0× 888 1.9× 228 0.6× 321 1.3× 144 2.0k
Stephen G. Chun United States 19 981 0.9× 687 1.2× 265 0.6× 363 1.0× 232 0.9× 67 1.6k
Sung Whan Ha South Korea 29 724 0.6× 892 1.6× 636 1.4× 248 0.7× 295 1.2× 126 2.1k
Nima Nabavizadeh United States 18 384 0.3× 358 0.6× 313 0.7× 248 0.7× 140 0.5× 73 1.1k
Jeong Il Yu South Korea 23 426 0.4× 444 0.8× 449 1.0× 162 0.4× 135 0.5× 117 1.5k
Éric Dansin France 19 1.8k 1.5× 1.4k 2.4× 127 0.3× 293 0.8× 376 1.5× 113 2.4k
Wei‐Xiang Qi China 24 940 0.8× 1.1k 2.0× 391 0.8× 186 0.5× 426 1.7× 109 2.1k
Katja Lindel Germany 22 466 0.4× 708 1.2× 610 1.3× 137 0.4× 322 1.3× 60 1.9k
Yasuhisa Ohde Japan 27 1.6k 1.4× 875 1.5× 382 0.8× 412 1.1× 356 1.4× 160 2.5k

Countries citing papers authored by Zhouguang Hui

Since Specialization
Citations

This map shows the geographic impact of Zhouguang Hui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhouguang Hui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhouguang Hui more than expected).

Fields of papers citing papers by Zhouguang Hui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhouguang Hui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhouguang Hui. The network helps show where Zhouguang Hui may publish in the future.

Co-authorship network of co-authors of Zhouguang Hui

This figure shows the co-authorship network connecting the top 25 collaborators of Zhouguang Hui. A scholar is included among the top collaborators of Zhouguang Hui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhouguang Hui. Zhouguang Hui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Shuai, Qingsong Pang, Qiang Lin, et al.. (2025). Radiotherapy combined with chemoimmunotherapy improves survival compared to chemoimmunotherapy alone as first-line treatment for oligometastatic esophageal squamous cell carcinoma. Strahlentherapie und Onkologie. 201(10). 979–991. 1 indexed citations
2.
3.
4.
Verma, Vivek, Carl M. Gay, Yujia Chen, et al.. (2023). Neoadjuvant immunotherapy for advanced, resectable non–small cell lung cancer: A systematic review and meta‐analysis. Cancer. 129(13). 1969–1985. 20 indexed citations
5.
6.
Ma, Li, Yu Men, Jingjing Kang, et al.. (2019). A current review of dose-escalated radiotherapy in locally advanced non-small cell lung cancer. Radiology and Oncology. 53(1). 6–14. 32 indexed citations
7.
Luo, Aiping, Xuantong Zhou, Xing Shi, et al.. (2019). Exosome-derived miR-339-5p mediates radiosensitivity by targeting Cdc25A in locally advanced esophageal squamous cell carcinoma. Oncogene. 38(25). 4990–5006. 108 indexed citations
8.
Kang, Jingjing, et al.. (2019). Tumor Mutation Load: A Novel Independent Prognostic Factor in Stage IIIA-N2 Non-Small-Cell Lung Cancer. Disease Markers. 2019. 1–10. 6 indexed citations
9.
Gong, Mengchun, Shuang Wang, Jianyang Wang, et al.. (2019). Evaluation of Privacy Risks of Patients’ Data in China: Case Study. JMIR Medical Informatics. 8(2). e13046–e13046. 12 indexed citations
10.
Kang, Jia, Zhouguang Hui, Yu Men, et al.. (2017). Optimal Timing of Postoperative Radiotherapy for Patients with Piiia-N2 Non-Small Cell Lung Cancer after Resection. International Journal of Radiation Oncology*Biology*Physics. 99(2). E466–E467. 1 indexed citations
11.
12.
Zhang, Wencheng, Qifeng Wang, Zefen Xiao, et al.. (2016). Postoperative prophylactic concurrent radiochemotherapy for node-positive esophageal squamous cell carcinoma: a phase I clinical study. Zhonghua fangshe zhongliuxue zazhi. 25(1). 26–31. 1 indexed citations
13.
Hui, Zhouguang, et al.. (2014). Comparation of set-up errors between two different body positions in precision radiotherapy for esophageal cancer. Zhonghua fangshe zhongliuxue zazhi. 23(4). 336–339. 2 indexed citations
14.
Zhang, Ye, Zhouguang Hui, Zihao Yu, et al.. (2014). Survey on the use of radiotherapy to treat early breast cancer following breast-conserving surgery in China.. PubMed. 100(5). 512–7. 2 indexed citations
15.
Xu, Huimin, Jianzhong Cao, Jingbo Wang, et al.. (2013). Management and outcome of symptomatic radiation induced lung injury in non-small cell lung cancer. Zhonghua fangshe zhongliuxue zazhi. 22(3). 201–204. 3 indexed citations
16.
Hui, Zhouguang, Zihao Yu, Xin-Fan Liu, et al.. (2012). Survey on use of radiotherapy for breast cancer following breast-conserving surgery in mainland China. Zhonghua fangshe zhongliuxue zazhi. 21(3). 241–246. 1 indexed citations
17.
Fan, Chengcheng, Qinfu Feng, Yirui Zhai, et al.. (2012). Analysis of treatment outcome for stage III thymoma. Zhonghua fangshe zhongliuxue zazhi. 21(6). 513–517. 1 indexed citations
18.
Hui, Zhouguang, Zhang Ye, Zihao Yu, et al.. (2012). Improvement in postmastectomy radiotherapy for breast cancer in mainland China:comparison of survey in 2010 with 2004. Zhonghua fangshe zhongliuxue zazhi. 21(4). 352–356.
19.
Zhang, Xiaodong, Thomas Guerrero, Sean E. McGuire, et al.. (2008). Four-Dimensional Computed Tomography–Based Treatment Planning for Intensity-Modulated Radiation Therapy and Proton Therapy for Distal Esophageal Cancer. International Journal of Radiation Oncology*Biology*Physics. 72(1). 278–287. 99 indexed citations
20.
Mai, W., Bin S. Teh, Haiquan Lu, et al.. (2006). 2370. International Journal of Radiation Oncology*Biology*Physics. 66(3). S415–S416. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zongmei Zhou Breakdown of academic impact, for papers by Zefen Xiao Breakdown of academic impact, for papers by Stephen G. Chun Breakdown of academic impact, for papers by Sung Whan Ha Breakdown of academic impact, for papers by Nima Nabavizadeh Breakdown of academic impact, for papers by Jeong Il Yu Breakdown of academic impact, for papers by Éric Dansin Breakdown of academic impact, for papers by Wei‐Xiang Qi Breakdown of academic impact, for papers by Katja Lindel Breakdown of academic impact, for papers by Yasuhisa Ohde
Rankless by CCL
2026